 SARASOTA, Fla., March 29, 2021 PRNewswire -- INVO Bioscience, Inc. NASDAQ: INVO, a medical device company focused on commercializing the worlds only in vivo Intravaginal Culture System IVC, INVOcell, an effective and affordable treatment for patients diagnosed with infertility, announced today that it will present at the Lytham Partners Spring 2021 Investor Conference on Thursday, April 1, 2021 at 4:15pm ET. 